A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib ; volume:12 ; number:1 ; day:29 ; month:11 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (29.11.2022), 1-10, 12.2022
- Creator
-
Guo, Menglin
Shu, Yamin
Chen, Guosong
Li, Juan
Li, Feie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-23726-4
- URN
-
urn:nbn:de:101:1-2023020921471768079717
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guo, Menglin
- Shu, Yamin
- Chen, Guosong
- Li, Juan
- Li, Feie
- SpringerLink (Online service)
Other Objects (12)
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System